Of note, a single cDC1 marker, CLEC9A, was also prognostic of patient survival (Figure 7G) and the cDC1 signature was at least as powerful a predictor of cancer patient survival as a CD8 T cell signature (Figure 7H). Here, CLEC9A is linked to cancer.